Notice2025-06834

Medicare Program; Virtual Meeting of the Medicare Evidence Development and Coverage Advisory Committee

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
April 21, 2025

Issuing agencies

Health and Human Services DepartmentCenters for Medicare & Medicaid Services

Abstract

This notice announces a virtual public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) ("Committee") will be held on Wednesday, June 25, 2025.

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 75 (Monday, April 21, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 75 (Monday, April 21, 2025)]
[Notices]
[Pages 16689-16691]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-06834]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3470-N]


Medicare Program; Virtual Meeting of the Medicare Evidence 
Development and Coverage Advisory Committee

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces a virtual public meeting of the Medicare 
Evidence Development & Coverage Advisory Committee (MEDCAC) 
(``Committee'') will be held on Wednesday, June 25, 2025.

DATES: 
    Meeting Date: The virtual meeting will be held on Wednesday, June 
25, 2025, from 10:00 a.m. until 4:00 p.m., Eastern Daylight Time (EDT).
    Deadline for Submission of Written Comments: Written comments must 
be received at the email address specified in the ADDRESSES section of 
this notice by 5:00 p.m., EDT, on Wednesday, May 21, 2025. Once 
submitted, all comments are final.
    Deadlines for Speaker Registration and Presentation Materials: The 
deadline to register as a speaker and to submit PowerPoint presentation 
materials and writings that will be used in support of an oral 
presentation, is 5:00 p.m., EDT on Wednesday, May 21, 2025. Speakers 
may register via email by contacting the person listed in the FOR 
FURTHER INFORMATION CONTACT section of this notice. Presentation 
materials must be received at the email address specified in the 
ADDRESSES section of this notice.
    Deadline for All Other Attendees Registration: Individuals who want 
to join the meeting may register online at: <a href="https://cms.zoomgov.com/meeting/register/vJIsfuiuqTooHSfrDZdYHzCLsztgUqyaxvo">https://cms.zoomgov.com/meeting/register/vJIsfuiuqTooHSfrDZdYHzCLsztgUqyaxvo</a> until 10:00 a.m., 
EDT on Wednesday, June 25, 2025.
    Deadline for Submitting a Request for Special Accommodations: 
Individuals viewing or listening to the meeting who

[[Page 16690]]

are hearing or visually impaired and have special requirements, or a 
condition that requires special assistance, should send an email to the 
MEDCAC Coordinator as specified in the FOR FURTHER INFORMATION CONTACT 
section of this notice no later than 5:00 p.m., EDT on Wednesday, May 
21, 2025.

ADDRESSES: To allow for broader public participation in the meeting, 
the Panel meeting will be held virtually.
    Submission of Presentations and Written Comments: Presentation 
materials and written comments that will be presented at the meeting 
must be submitted via email to <a href="/cdn-cgi/l/email-protection#e9a48c8daaa8aa999b8c9a8c879d889d8086879aa98a849ac781819ac78e869f"><span class="__cf_email__" data-cfemail="d19cb4b5929092a1a3b4a2b4bfa5b0a5b8bebfa291b2bca2ffb9b9a2ffb6bea7">[email&#160;protected]</span></a>. All 
comments, presentations and articles/background materials will be 
posted on the MEDCAC website.
    Webinar and Teleconference Meeting Information: Teleconference 
dial-in instructions, and related webinar details will be posted on the 
meeting agenda, which will be available on the CMS website <a href="https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&">https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&</a>. Participants in the MEDCAC meeting will 
require the following: a computer, laptop or smartphone where the Zoom 
application needs to be downloaded; a strong Wi-Fi or an internet 
connection and access to use Chrome or Firefox web browser and a webcam 
if the meeting participant is scheduled to speak or make a presentation 
during the meeting.

FOR FURTHER INFORMATION CONTACT: Tara Hall, MEDCAC Coordinator, via 
email at <a href="/cdn-cgi/l/email-protection#422f27262123211d3027252b31363023362b2d2c02212f316c2a2a316c252d34"><span class="__cf_email__" data-cfemail="78151d1c1b191b270a1d1f110b0c0a190c111716381b150b5610100b561f170e">[email&#160;protected]</span></a> or by phone 410-786-4347.

SUPPLEMENTARY INFORMATION:

I. Background

    MEDCAC, formerly known as the Medicare Coverage Advisory Committee 
(MCAC), is advisory in nature, with all final coverage decisions 
resting with CMS. MEDCAC is used to supplement CMS' internal expertise. 
Accordingly, the advice rendered by the MEDCAC is most useful when it 
results from a process of full scientific inquiry and thoughtful 
discussion, in an open forum, with careful framing of recommendations 
and clear identification of the basis of those recommendations. MEDCAC 
members are valued for their background, education, and expertise in a 
wide variety of scientific, clinical, and other related fields. (For 
more information on MEDCAC, see the MEDCAC Charter (<a href="https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/Downloads/medcaccharter.pdf">https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/Downloads/medcaccharter.pdf</a>) and the CMS Guidance Document, Factors CMS Considers 
in Referring Topics to the MEDCAC <a href="https://www.cms.gov/medicare-coverage-database/details/medicare-coverage-document-details.aspx?MCDId=10">https://www.cms.gov/medicare-coverage-database/details/medicare-coverage-document-details.aspx?MCDId=10</a>).

II. Meeting Topic and Format

    This notice announces the Wednesday, June 25, 2025, virtual public 
meeting of the Committee. The MEDCAC panel will examine which clinical 
endpoints in studies of devices to manage tremor in Parkinson's disease 
and essential tremor should be of interest to CMS. Given the increased 
emphasis on new and innovative medical products for difficult-to-manage 
conditions, some studies of new medical technologies have focused on 
short-term data with greater reliance on intermediate outcomes and 
surrogate endpoints. Furthermore, studies of new devices are often not 
representative of the Medicare beneficiary population in terms of 
demographics, comorbidity prevalence or care setting. As a result, 
there are more frequent evidence gaps with respect to the health 
outcomes that are clinically meaningful for CMS beneficiaries in 
assessments of medical technologies. The MEDCAC panel will consider a 
review of the relevant clinical research and professional guidance 
literature, along with expert commentary. By voting on specific 
questions, and by their discussions, MEDCAC panel members will advise 
CMS about the ideal clinical endpoints in research studies of devices 
to manage tremor in Parkinson's disease and essential tremor, as well 
as appropriate measurement instruments and follow-up durations, to help 
to provide clarity and transparency of National Coverage Analyses 
(NCAs). This meeting is open to the public in accordance with the 
Federal Advisory Committee Act (5 U.S.C. app. 2, section 10(a)).
    Background information about this topic, including panel materials, 
is available at <a href="https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&">https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&</a>. Electronic copies of all 
the meeting materials, to include public comments and presentations, 
will be on the CMS website approximately 15 days before the meeting. We 
encourage the participation of organizations with expertise in the 
appraisal of the state of evidence for the use of device to manage 
tremor in Parkinson's disease and essential tremor. This meeting is 
open to the public. The Committee will hear oral presentations from the 
public for approximately 45 minutes. Time allotted for each 
presentation may be limited, based on the number of speakers. If the 
number of registrants requesting to speak is greater than what can be 
reasonably accommodated during the scheduled open public hearing 
session, we may conduct a lottery to determine the speakers for the 
scheduled open public hearing session. The contact person will notify 
interested persons regarding their request to speak by June 4, 2025. 
Your comments must focus on issues specific to the list of topics that 
we have proposed to the Committee. The list of research topics to be 
discussed at the meeting will be available on the following website 
prior to the meeting: <a href="https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&">https://www.cms.gov/medicare-coverage-database/indexes/medcac-meetings-index.aspx?bc=BAAAAAAAAAAA&</a>. We require that 
you declare at the meeting whether you have any financial involvement 
with manufacturers (or their competitors) of any items or services 
being discussed. Speakers presenting at the MEDCAC meeting must include 
a full disclosure slide as their second slide in their presentation for 
financial interests (for example, type of financial association--
consultant, research support, advisory board, and an indication of 
level, such as minor association < $10,000 or major association > 
$10,000) as well as intellectual conflicts of interest (for example, 
involvement in a federal or nonfederal advisory committee that has 
discussed the issue) that may pertain in any way to the subject of this 
meeting. If you are representing an organization, we require that you 
also disclose conflict of interest information for that organization. 
If you do not have a PowerPoint presentation, you will need to present 
the full disclosure information requested previously at the beginning 
of your statement to the Committee.
    The Committee will deliberate openly on the topics under 
consideration. Interested persons may observe the deliberations, but 
the Committee will not hear further comments during this time except at 
the request of the chairperson. The Committee will also allow a 15-
minute unscheduled open public session for any attendee to address 
issues specific to the topics under consideration. At the conclusion of 
the day, the members will vote, and the Committee will make its 
recommendation(s) to CMS.

III. Registration Instructions

[[Page 16691]]

    CMS' Coverage and Analysis Group is coordinating meeting 
registration. While there is no registration fee, individuals must 
register to attend. You may register online at <a href="https://cms.zoomgov.com/meeting/register/vJIsfuiuqTooHSfrDZdYHzCLsztgUqyaxvo">https://cms.zoomgov.com/meeting/register/vJIsfuiuqTooHSfrDZdYHzCLsztgUqyaxvo</a> or by email by 
contacting the person listed in the FOR FURTHER INFORMATION CONTACT 
section of this notice by the deadline listed in the DATES section of 
this notice. Please provide your full name (as it appears on your 
state-issued driver's license), address, organization, telephone 
number(s), and email address. You will receive a registration 
confirmation with instructions for your participation at the virtual 
public meeting.

IV. Collection of Information

    This document does not impose information collection requirements, 
that is, reporting, recordkeeping or third-party disclosure 
requirements. Consequently, there is no need for review by the Office 
of Management and Budget under the authority of the Paperwork Reduction 
Act of 1995 (44 U.S.C. 35).
    The Chief Medical Officer and Acting Director of the Center for 
Clinical Standards and Quality for the Centers for Medicare & Medicaid 
Services (CMS), Dora Hughes, having reviewed and approved this 
document, authorizes Chyana Woodyard, who is the Federal Register 
Liaison, to electronically sign this document for purposes of 
publication in the Federal Register.

Chyana Woodyard,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2025-06834 Filed 4-18-25; 8:45 am]
BILLING CODE 4120-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on April 21, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.